Health campaigners accuse Philip Morris International of misrepresenting regulatory decisions to launch its heated tobacco device, IQOS, in the US.

Health campaigners, including the Campaign for Tobacco-Free Kids, American Academy of Pediatrics, and American Lung Association, have accused Philip Morris International of misrepresenting past regulatory decisions, seeking to disrupt the launch of its flagship heated tobacco device, IQOS, in the U.S. The world's largest tobacco firm by market value has spent billions developing the product, seen as crucial for future growth. However, it needs permission from the U.S. FDA to sell IQOS, the world's second-largest tobacco market by revenue. The campaigners claim PMI has made misleading statements suggesting that the FDA found IQOS to reduce disease risk.

July 16, 2024
6 Articles